Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Cash from Investing Activities came in at -$487000.0 in Q2 2026, down 372.82% on a YoY basis from $178508.9 in Q2 2025, and down 299.18% quarter-over-quarter from -$122000.0 in Q1 2026.
Powered by 
Analysis
Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has reported Cash from Investing Activities for 17 consecutive years, with -$487000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 372.82% year-over-year to -$487000.0; the trailing twelve-month figure through Jun 2026 stood at -$9.0 million (down 38.19% YoY), and the FY2025 full-year result was -$8.5 million, down 75.59% from the prior year.
- Cash from Investing Activities declined to -$487000.0 in Q2 2026 per RMTI's latest filing, from -$122000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $9.1 million in Q1 2022 and bottomed at -$14.7 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$1.1 million across 5 years, with a median of -$112500.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities jumped 2782.81% in 2024, then slumped 12100.0% in 2026.
- Over 5 years, Cash from Investing Activities stood at $3.2 million in 2022, then slumped by 37.6% to $2.0 million in 2023, then plunged by 116.53% to -$332000.0 in 2024, then tumbled by 1144.28% to -$4.1 million in 2025, then jumped by 88.21% to -$487000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$487000.0, -$122000.0, and -$4.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | -241.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | -461.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | -43.20 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | -117.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | -74.27 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | -1.07 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -487,000.00 |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 1.81 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -487,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -6.11 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | -139,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | -10.29 Mn |
| Jun 30, 2023 | -64,000.00 |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | -14.70 Mn |
| Jun 30, 2022 | -51,000.00 |
| Mar 31, 2022 | 9.13 Mn |
| Dec 31, 2021 | 540,000.00 |
| Sep 30, 2021 | -1.36 Mn |